In a research report issued Monday, H.C.
In a report issued today, H.C.
In a research report issued today, H.C.
In a research note published today, H.C.
In a research report released August 8, H.C.
In a research note published August 8th, H.C.
In a research report released yesterday, H.C.
In a research note published today, H.C Wainwright analyst Andrew Fein reaffirmed a Buy rating on Insmed (INSM) with a $30 price target, …
In a research note released today, H.C.
In a research report released yesterday, HC Wainwright analyst Andrew Fein reiterated a Buy rating on United Therapeutics Corp. (UTHR) and raised his price …
